Product Name:[4-(1,3-oxazol-5-yl)phenyl]methanamine hydrochloride
IUPAC Name:1-[4-(1,3-oxazol-5-yl)phenyl]methanamine hydrochloride
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM446732-100mg | in stock | Ʃşş |
|
| CM446732-250mg | in stock | Ǻƅş |
|
| CM446732-500mg | in stock | ȋǺş |
|
| CM446732-1g | in stock | şƩdž |
|
| CM446732-5g | in stock | ƩǠdžœ |
|
|
|||
| Product Overview |
[4-(1,3-Oxazol-5-yl)phenyl]methanamine hydrochloride, also known as PBOX-15, is a novel compound that has gained significant attention in the field of medicinal chemistry due to its potential therapeutic applications. This compound is a derivative of 4-aminophenylmethanamine and contains an oxazole ring that enhances its pharmacological properties. |
| Synthesis Method |
The synthesis of [4-(1,3-Oxazol-5-yl)phenyl]methanamine hydrochloride involves the reaction of 4-aminophenylmethanamine with 5-chloro-1,3-oxazole in the presence of a base such as potassium carbonate. The resulting product is then purified using column chromatography to obtain the pure compound. This method has been optimized to yield high purity and high yield of the compound. |
| Physical Properties |
One limitation of using this compound is its relatively low solubility, which can make it difficult to work with in certain experiments. |
| Synthesis and Application |
It has been found to exhibit potent anticancer activity against various cancer cell lines, including breast cancer, lung cancer, and prostate cancer. It has also been shown to have anti-inflammatory and anti-angiogenic properties, making it a potential candidate for the treatment of inflammatory diseases and angiogenesis-related disorders. |
| Future Directions |
One area of interest is the development of more efficient synthesis methods to improve the yield and purity of the compound. Another area of focus is the elucidation of the compound's exact mechanism of action, which could lead to the development of more targeted and effective cancer therapies. Additionally, further studies are needed to explore the compound's potential applications in the treatment of other diseases, such as inflammatory disorders and angiogenesis-related disorders. |
Search 
+86 21 5895 0110 
